PND38 RETURN ON INVESTMENT ANALYSIS OF AN EMPLOYER-PROVIDED MIGRAINE DISEASE MANAGEMENT PROGRAM PILOTED IN SWITZERLAND.

To perform a return-on-investment (ROI) analysis of a migraine tele-medicine disease management program, sponsored by a company within its wellness program for its Swiss-based employees and their family members, to foster patient empowerment to multidisciplinary approaches in the management of their migraine. Conclusions This analysis concludes that the migraine disease management program has a high ROI informing other employers that the systematic inclusion of migraine management into corporate health management programs can be of significant benefit to the impacted individuals as well as the companies. [Extracted from the article]